心房颤动外科消融与单纯左心耳封闭相比与改善生存相关:对10万例医疗保险受益人的分析
基于美国医疗保险2018年1月至2020年12月住院索赔数据,纳入103,382例65岁及以上术前房颤且接受冠脉搭桥或瓣膜手术的患者,比较外科消融+左心耳封闭、单纯左心耳封闭与未处理房颤的结局。风险调整后,外科消融+左心耳封闭与3年死亡率降低独立相关(HR 0.68,P<.001)及栓塞性卒中再入院减少相关(HR 0.77,P=.009),且3年死亡或卒中复合终点优于单纯左心耳封闭(HR 0.90,P=.035)。
要点
- 外科消融+左心耳封闭与未处理房颤相比,3年死亡率HR 0.68(P<.001)。
- 外科消融+左心耳封闭与单纯左心耳封闭相比,3年死亡率HR 0.90(P<.001)。
- 两种左心耳干预均与栓塞性卒中再入院减少相关,复合终点消融+封闭优于单纯封闭。
核心结论
- 在因房颤接受心脏手术的医疗保险受益人中,外科管理房颤与较低的3年死亡率和卒中再入院相关,且外科消融+左心耳封闭较单纯左心耳封闭与更高的生存相关。
研究设计与样本
- 回顾性队列分析,使用美国医疗保险和医疗补助服务中心住院索赔数据库,纳入2018年1月至2020年12月期间65岁及以上、术前诊断房颤并接受冠脉搭桥或二尖瓣/主动脉瓣/三尖瓣修复或置换的全部受益人,共103,382例。
- 采用倾向评分逆概率加权回归分析和Cox比例风险模型进行风险调整,并按主要手术及阵发性或持续性房颤进行亚组分析。
主要发现
- 103,382例患者中,外科消融+左心耳封闭10,437例(10.1%),单纯左心耳封闭12,901例(12.5%),未处理房颤80,044例(77.4%)。
- 开放心房手术(二尖瓣/三尖瓣)患者17,204例(16.6%),其中外科消融+左心耳封闭5,267例(30.6%),单纯左心耳封闭4,259例(24.8%),未处理房颤7,678例(44.6%)。
- 风险调整后,外科消融+左心耳封闭与未处理房颤相比,3年死亡率降低(HR 0.68,P<.001);与单纯左心耳封闭相比,3年死亡率亦降低(HR 0.90,P<.001)。
- 与未处理房颤相比,栓塞性卒中再入院在外科消融+左心耳封闭(HR 0.77,P=.009)和单纯左心耳封闭(HR 0.73,P<.001)均较低;外科消融+左心耳封闭的3年死亡或卒中复合终点优于单纯左心耳封闭(HR 0.90,P=.035)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Societal guidelines support the concomitant surgical ablation of atrial fibrillation in patients undergoing cardiac surgery. Recent evidence has highlighted the stroke reduction of left atrial appendage obliteration with or without surgical ablation in similar populations. To inform clinical decision-making, we evaluated real-world outcomes of patients with atrial fibrillation undergoing cardiac surgery by comparing no atrial fibrillation management with left atrial appendage obliteration alone versus surgical ablation + left atrial appendage obliteration. METHODS: By using the US Centers for Medicare and Medicaid Services inpatient claims database, we evaluated all beneficiaries aged 65 years and older with a diagnosis of atrial fibrillation undergoing coronary artery bypass grafting or mitral/aortic/tricuspid valve repair or replacement between January 2018 and December 2020. Diagnosis-related group and International Classification of Diseases, 10th Revision procedure codes were used to define variables. Risk adjustment was performed with regression analysis using inverse probability weighting of propensity scores and Cox proportional hazards models. Subgroup analyses stratified patients by primary operation and paroxysmal or persistent atrial fibrillation. RESULTS: A total of 103,382 patients with preoperative atrial fibrillation were stratified by surgical ablation + left atrial appendage obliteration (10,437; 10.1%), left atrial appendage obliteration alone (12,901; 12.5%), or no atrial fibrillation management (80,044; 77.4%). Patients with persistent atrial fibrillation (21,076; 20.4%) received the highest proportion of surgical ablation + left atrial appendage obliteration (4661 19.4%) and left atrial appendage obliteration alone (3%724%; 15.4%) versus no atrial fibrillation management (15,688; 65.2%). Likewise, patients undergoing open atrial operations (mitral/tricuspid; 17,204; 16.6%) had higher proportions of atrial fibrillation treatment (surgical ablation + left atrial appendage obliteration 5267 30.6%; left atrial appendage obliteration alone 4259 24.8%; no atrial fibrillation management 7678 44.6%). After robust risk adjustment, surgical ablation + left atrial appendage obliteration was independently associated with reduced 3-year mortality compared with no atrial fibrillation treatment (hazard ratio, 0.68, P < .001) and left atrial appendage obliteration alone (hazard ratio, 0.90, P < .001). Compared with no atrial fibrillation treatment, readmissions for embolic stroke were lower with both surgical ablation + left atrial appendage obliteration (hazard ratio, 0.77, P = .009) and left atrial appendage obliteration alone (hazard ratio, 0.73, P < .001). Reduction in 3-year composite mortality or stroke after surgical ablation + left atrial appendage obliteration was superior to left atrial appendage alone (hazard ratio, 0.90, P = .035). CONCLUSIONS: In Medicare beneficiaries with atrial fibrillation undergoing cardiac surgery, the surgical management of atrial fibrillation was associated with lower 3-year mortality and readmission for stroke, with surgical ablation + left atrial appendage obliteration being associated with higher survival compared with left atrial appendage obliteration alone.
引用
- Mehaffey JH, Hayanga JWA, Wei L, et al. Surgical ablation of atrial fibrillation is associated with improved survival compared with appendage obliteration alone: An analysis of 100,000 Medicare beneficiaries. J Thorac Cardiovasc Surg. 2023. PMID: 37160223. doi:10.1016/j.jtcvs.2023.04.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。